Stay updated on Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial
Sign up to get notified when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.

Latest updates to the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page
- CheckyesterdayChange DetectedThe study is no longer looking for participants, indicating enrollment has halted. The history also shows a new revision labeled v3.6.0 and the previous revision v3.5.5 has been removed from the record history.SummaryDifference0.6%

- Check8 days agoChange DetectedA new revision entry v3.5.5 was added to the record history to replace the previous revision v3.5.4, indicating an update to the study record.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe record history shows a new latest revision (v3.5.4) replacing the previous (v3.5.3), indicating an update to the page's text and layout captured in the revision.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page footer updates the displayed software revision from v3.5.2 to v3.5.3, reflecting a minor system/interface update rather than a change to the trial’s record history.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 in the study record history.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision v3.5.0 was added to the history and v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.